KR102405199B1 - 설카딘 염 - Google Patents
설카딘 염 Download PDFInfo
- Publication number
- KR102405199B1 KR102405199B1 KR1020217027357A KR20217027357A KR102405199B1 KR 102405199 B1 KR102405199 B1 KR 102405199B1 KR 1020217027357 A KR1020217027357 A KR 1020217027357A KR 20217027357 A KR20217027357 A KR 20217027357A KR 102405199 B1 KR102405199 B1 KR 102405199B1
- Authority
- KR
- South Korea
- Prior art keywords
- salt
- sulfadine
- crystalline
- peaks
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/32—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of salts of sulfonic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/42—Separation; Purification; Stabilisation; Use of additives
- C07C303/44—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C309/05—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing at least two sulfo groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Inorganic Chemistry (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020227017874A KR102697726B1 (ko) | 2019-01-29 | 2020-01-28 | 설카딘 염 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962798467P | 2019-01-29 | 2019-01-29 | |
| US62/798,467 | 2019-01-29 | ||
| US202062959687P | 2020-01-10 | 2020-01-10 | |
| US62/959,687 | 2020-01-10 | ||
| PCT/US2020/015370 WO2020159959A1 (en) | 2019-01-29 | 2020-01-28 | Sulcardine salts |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020227017874A Division KR102697726B1 (ko) | 2019-01-29 | 2020-01-28 | 설카딘 염 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20210130157A KR20210130157A (ko) | 2021-10-29 |
| KR102405199B1 true KR102405199B1 (ko) | 2022-06-02 |
Family
ID=69724142
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020217027357A Active KR102405199B1 (ko) | 2019-01-29 | 2020-01-28 | 설카딘 염 |
| KR1020227017874A Active KR102697726B1 (ko) | 2019-01-29 | 2020-01-28 | 설카딘 염 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020227017874A Active KR102697726B1 (ko) | 2019-01-29 | 2020-01-28 | 설카딘 염 |
Country Status (16)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020123824A1 (en) | 2018-12-13 | 2020-06-18 | Huya Bioscience International, Llc | Sulcardine administration for treatment of acute atrial fibrillation |
| KR102405199B1 (ko) * | 2019-01-29 | 2022-06-02 | 후야 바이오사이언스 인터내셔널 엘엘씨 | 설카딘 염 |
| US11813245B2 (en) * | 2020-06-12 | 2023-11-14 | Huyabio International, Llc | Sulcardine administration for treatment of acute atrial fibrillation |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001042204A1 (en) | 1999-12-10 | 2001-06-14 | Shanghai Institute Of Materia Medica Chinese Academy Of Science | N-substituted benzyl or phenyl aromatic sulfamides compounds and the use thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1299813C (zh) | 2004-12-28 | 2007-02-14 | 华南理工大学 | 自动撕膜落料及多样性搅拌的机构和控制装置 |
| CN1939298A (zh) * | 2005-09-29 | 2007-04-04 | 中国科学院上海药物研究所 | 硫酸舒欣啶固体和靶向制剂及其制备方法 |
| US8541464B2 (en) | 2009-11-17 | 2013-09-24 | HUYA Biosciences International LLC | Treatment of atrial fibrillation |
| WO2011062903A2 (en) * | 2009-11-17 | 2011-05-26 | Elliott Gary T | Slow infusion of sulcardine and its salts |
| MA41599A (fr) * | 2015-02-26 | 2018-01-02 | Array Biopharma Inc | Formes cristallines d'un composé pyrrolopyridine |
| EP3302442B1 (en) | 2015-06-03 | 2024-10-16 | Triastek, Inc. | Dosage forms and use thereof |
| AU2017261372B2 (en) | 2016-05-05 | 2019-02-14 | Triastek, Inc. | Controlled release dosage form |
| AU2018212273B2 (en) | 2017-01-26 | 2023-12-21 | Triastek, Inc. | Dosage forms of controlled release at specific gastrointestinal sites |
| US10370381B2 (en) * | 2017-02-24 | 2019-08-06 | Gilead Sciences, Inc. | Inhibitors of bruton'S tyrosine kinase |
| WO2020123824A1 (en) | 2018-12-13 | 2020-06-18 | Huya Bioscience International, Llc | Sulcardine administration for treatment of acute atrial fibrillation |
| KR102405199B1 (ko) * | 2019-01-29 | 2022-06-02 | 후야 바이오사이언스 인터내셔널 엘엘씨 | 설카딘 염 |
-
2020
- 2020-01-28 KR KR1020217027357A patent/KR102405199B1/ko active Active
- 2020-01-28 IL IL285184A patent/IL285184B2/en unknown
- 2020-01-28 AU AU2020216925A patent/AU2020216925B2/en active Active
- 2020-01-28 WO PCT/US2020/015370 patent/WO2020159959A1/en not_active Ceased
- 2020-01-28 CA CA3128152A patent/CA3128152A1/en active Pending
- 2020-01-28 CN CN202080004796.1A patent/CN112638903B/zh active Active
- 2020-01-28 SG SG11202108160YA patent/SG11202108160YA/en unknown
- 2020-01-28 CN CN202211089980.8A patent/CN115385871A/zh active Pending
- 2020-01-28 JP JP2021542541A patent/JP2022518906A/ja active Pending
- 2020-01-28 KR KR1020227017874A patent/KR102697726B1/ko active Active
- 2020-01-28 PH PH1/2021/551818A patent/PH12021551818A1/en unknown
- 2020-01-28 EP EP20707973.2A patent/EP3917921A1/en active Pending
- 2020-01-28 MX MX2021009033A patent/MX2021009033A/es unknown
- 2020-01-28 US US16/775,142 patent/US11426382B2/en active Active
- 2020-01-28 BR BR112021014640A patent/BR112021014640A8/pt unknown
- 2020-10-23 US US17/079,347 patent/US11020374B2/en active Active
-
2021
- 2021-07-27 MX MX2023014776A patent/MX2023014776A/es unknown
- 2021-07-27 CL CL2021001968A patent/CL2021001968A1/es unknown
- 2021-07-28 ZA ZA2021/05344A patent/ZA202105344B/en unknown
- 2021-08-23 CO CONC2021/0011042A patent/CO2021011042A2/es unknown
- 2021-10-05 ZA ZA2021/07474A patent/ZA202107474B/en unknown
-
2022
- 2022-07-11 US US17/862,117 patent/US12678422B2/en active Active
-
2023
- 2023-11-02 JP JP2023188791A patent/JP2024039020A/ja active Pending
-
2025
- 2025-07-07 JP JP2025114666A patent/JP2025165933A/ja active Pending
-
2026
- 2026-01-28 US US19/462,309 patent/US20260232630A1/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001042204A1 (en) | 1999-12-10 | 2001-06-14 | Shanghai Institute Of Materia Medica Chinese Academy Of Science | N-substituted benzyl or phenyl aromatic sulfamides compounds and the use thereof |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220356319A1 (en) | Sulcardine salts | |
| ES2562843T3 (es) | Forma IV de clorhidrato de ivabradina | |
| BR112020022738A2 (pt) | formas cristalinas de um inibidor tlr7/tlr8 | |
| US10206916B2 (en) | Cabozantinib salts and their use as anti-cancer agents | |
| US8361971B2 (en) | Tablet formulation of ezatiostat | |
| ES2949414T3 (es) | Formas cristalinas de 4-(2-((1R,2R)-2-hidroxiciclohexilamino)benzotiazol-6-iloxi)-N-metilpicolinamida | |
| HK40049638B (en) | Sulcardine salts | |
| HK40079384A (en) | Sulcardine salts | |
| HK40049638A (en) | Sulcardine salts | |
| EA043571B1 (ru) | Соли сулькардина | |
| AU2019344541B2 (en) | Erbumine salt of treprostinil | |
| DK2909169T3 (en) | CRYSTALLINIC PHASE OF (3S, 3S ') 4,4'-DISULPHANDYLBIS (3-AMINOBUTANE 1-SULPHONIC ACID) WITH L-LYSINE | |
| CN105367622B (zh) | 一种阿加曲班化合物 | |
| CN107793356B (zh) | 一种四氢异喹啉的盐衍生物及其晶体的制备方法和应用 | |
| TWI898321B (zh) | 用於治療或預防高尿酸血症或痛風的化合物的固體晶型 | |
| KR20250026776A (ko) | 고요산혈증 또는 통풍 치료 또는 예방을 위한 화합물의 고체 결정형 | |
| EA043230B1 (ru) | Эрбуминовая соль трепростинила | |
| NZ759132B2 (en) | Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof | |
| NZ719970A (en) | Solid forms of { [5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid, compositions, and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| A302 | Request for accelerated examination | ||
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PA0105 | International application |
St.27 status event code: A-0-1-A10-A15-nap-PA0105 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| PA0302 | Request for accelerated examination |
St.27 status event code: A-1-2-D10-D17-exm-PA0302 St.27 status event code: A-1-2-D10-D16-exm-PA0302 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
St.27 status event code: A-1-2-D10-D22-exm-PE0701 |
|
| A107 | Divisional application of patent | ||
| PA0104 | Divisional application for international application |
St.27 status event code: A-0-1-A10-A18-div-PA0104 St.27 status event code: A-0-1-A10-A16-div-PA0104 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
St.27 status event code: A-2-4-F10-F11-exm-PR0701 |
|
| PR1002 | Payment of registration fee |
St.27 status event code: A-2-2-U10-U12-oth-PR1002 Fee payment year number: 1 |
|
| PG1601 | Publication of registration |
St.27 status event code: A-4-4-Q10-Q13-nap-PG1601 |
|
| PN2301 | Change of applicant |
St.27 status event code: A-5-5-R10-R13-asn-PN2301 St.27 status event code: A-5-5-R10-R11-asn-PN2301 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 4 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-OTH-PR1001 (AS PROVIDED BY THE NATIONAL OFFICE) Year of fee payment: 4 |